Abstract | CONTEXT: OBJECTIVE: We describe a 14-yr-old female with clinical and hormonal features of 17alpha- hydroxylase/ 17,20-lyase deficiency and identify and characterize the activities of her CYP17A1 mutations. METHODS: The coding regions of the CYP17A1 gene were amplified by PCR and sequenced. Mutations were recreated in P450c17 cDNA expression vectors; activities in transfected COS-1 cells were assayed by conversion of radiolabeled precursor steroids. One mutant was also expressed in Escherichia coli, and the reduced adsorption spectrum was measured. RESULTS: The patient carried the previously described mutation R96W and the novel missense mutation H373D. Neither mutant had detectable activity when expressed in COS-1 cells. Membrane preparations from E. coli expressing the H373D mutant vector produced an absorption peak at 420 nm, whereas the wild-type produced a peak at 450 nm, suggesting that the H373D mutation interferes with protein folding. CONCLUSION: The novel P450c17 mutation H373D abolished enzyme activity because of protein misfolding. These data indicate an important role for this residue in P450c17 activity.
|
Authors | Taninee Sahakitrungruang, Meng Kian Tee, Phyllis W Speiser, Walter L Miller |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 94
Issue 8
Pg. 3089-92
(Aug 2009)
ISSN: 1945-7197 [Electronic] United States |
PMID | 19470621
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Steroid 17-alpha-Hydroxylase
|
Topics |
- Adolescent
- Adrenal Hyperplasia, Congenital
(genetics)
- Female
- Humans
- Mutation
- Steroid 17-alpha-Hydroxylase
(chemistry, genetics)
|